Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-08-30 21:40:37 UTC |
---|
Update Date | 2021-09-26 22:48:57 UTC |
---|
HMDB ID | HMDB0242425 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol |
---|
Description | AC1L9XJ3 belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. AC1L9XJ3 is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). (1s,17r)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=C(O)C=C12 InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C19H24N2O |
---|
Average Molecular Weight | 296.414 |
---|
Monoisotopic Molecular Weight | 296.188863401 |
---|
IUPAC Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol |
---|
Traditional Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=C(O)C=C12 |
---|
InChI Identifier | InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3 |
---|
InChI Key | RAUCDOKTMDOIPF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Ibogan-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Ibogan-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Ibogan skeleton
- Catharanthine skeleton
- Hydroxyindole
- Pyrroloazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- Azepine
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Tertiary amine
- Tertiary aliphatic amine
- Organoheterocyclic compound
- Azacycle
- Organooxygen compound
- Organonitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 2882.1 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 2917.4 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 3599.7 | Standard polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 2925.6 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 2846.3 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 3532.4 | Standard polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 2886.8 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 2815.4 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 3347.2 | Standard polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3110.7 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3185.4 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3715.2 | Standard polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3101.3 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3117.8 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3621.6 | Standard polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3261.7 | Semi standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3318.5 | Standard non polar | 33892256 | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3487.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | splash10-014i-1290000000-f4b5acd785b6c643f768 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Positive-QTOF | splash10-0002-0090000000-7a52ccd6b13581152274 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Positive-QTOF | splash10-0002-0090000000-7a52ccd6b13581152274 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Positive-QTOF | splash10-0400-0980000000-7591e714ad6a83186bf4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Negative-QTOF | splash10-0002-0090000000-6097eef1edfc41faed9b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Negative-QTOF | splash10-0002-0090000000-6097eef1edfc41faed9b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Negative-QTOF | splash10-00kf-0190000000-4198e3f8928f0e0784e6 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|